Abstract:Background: Recurrent eyelid sebaceous carcinoma (SC) after primary resection still remains a great challenge for ophthalmologists. The predictors of recurrence are multifactorial, the identification of core risk factors to construct an individualized prediction model is warranted. The purpose of this study is to develop and validate a nomogram for individualized recurrence prediction of eyelid SC and to determine the independent risk factors. Methods: A multicenter cohort study. The study included 418 consecutive patients with eyelid SC, and this sample was divided into training (n=293) and validation cohorts (n=125). Least absolute shrinkage and selection operator (LASSO) regression was applied to select the features for the nomogram. The model was evaluated using the receiver operating characteristic (ROC)-derived area under the curve (AUC), calibration plot, and decision-curve analyses (DCAs), and it was compared with the TNM staging system. These results were externally validated with bootstrap resampling in an independent cohort. Multivariate Cox regression was used to explore the independent predictors of recurrence. Findings: This nomogram displayed satisfactory discriminative ability and good calibration for both the training (C-index: 0.83; AUC: 0.84) and validation (C-index: 0.80; AUC: 0.82) cohorts. The discriminative ability compared significantly favorable than TNM staging (C-index: training cohort: 0.67, validation cohort: 0.71; AUC: training cohort: 0.67, validation cohort: 0.71; all p<0.05). DCA demonstrated that this nomogram was clinically useful. Multivariate Cox regression indicated that diagnostic delay (HR=1.01, 95%CI:1.00-1.01, p=0.001), orbital involvement (HR=4.47, 95%CI:3.04-6.58, p<0.001), Ki 67 (HR=1.01, 95%CI:1.00-1.02, p=0.008) and initial surgical modality (HR=0.53, 95%CI:0.35-0.80, p=0.003) were independent predictors of recurrence. Interpretation: This nomogram provides improved individualized estimates of recurrence after primary excision for Chinese patients with eyelid SC. This model may help guide therapeutic decisions in clinical application. Funding Statement: This work was supported by the National Natural Science Foundation of China (Grants No. 81570884, 81770961) and Innovation Fund for Translational Medicine (15ZH1005), and the Shanghai Shuguang Project (14SG18). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Declaration of Interests: The authors state: No conflict of interest to declare. Ethics Approval Statement: The requirement for informed consent was waived by the institutional review board. The research ethics committees of Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine approved this study. This research strictly followed the tenets of the Declaration of Helsinki.

Sebaceous carcinoma of the eyelid: a clinicopathological study

Clinicopathologic Features And Prognostic Factors Of Malignant Eyelid Tumors

Recurrence in Eyelid Sebaceous Carcinoma: A Multicentric Study of 418 Patients.

Clinicopathological Analysis of 5146 Eyelid Tumours and Tumour-Like Lesions in an Eye Centre in South China, 2000–2018: a Retrospective Cohort Study

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

Updates On The Clinical Diagnosis And Management Of Ocular Sebaceous Carcinoma: A Brief Review Of The Literature

Clinicopathological Features of Patients with Wide Local Excision of Eyelid Malignant Neoplasms: a More Than Five Years Retrospective Study from China

Surgical management of facial malignant tumors

Ocular sebaceous gland carcinoma: an update of the literature

Excision and Delayed Reconstruction With Paraffin Section Histopathological Analysis for Periocular Sebaceous Carcinoma

Sebaceous hyperplasia of the eyelid: A comprehensive case report and literature review

Eyelid sebaceous gland carcinoma: a protocol for a systematic review and meta-analysis of clinicopathological studies of prevalence

Intraepithelial growth pattern for eyelid sebaceous carcinoma: a cohort of 214 patients from a single institution

Sebaceous Carcinoma of the Ocular Region: The 2014 Professor Winifred Mao Lecture

Individualized Prediction and Risk Factors of Recurrence in Chinese Patients with Sebaceous Carcinoma: A Multicenter Study of 418 Patients

A Clinical and Pathologic Study of Meibomian Gland Carcinoma with Reduplicative Operations

Clinical analysis and pathology for mucoepidermoid carcinoma of the eyelid

Molecular landscape of eyelid sebaceous gland carcinoma: A comprehensive review

Eyelid/Periocular Sebaceous Gland Carcinoma in 500 Eyes: Analysis Based on 8th Edition American Joint Cancer Committee Classification

[A clinicopathological classification analysis of ocular mass lesions in 7 910 cases].

Neoadjuvant Chemotherapy in Non-Metastatic Eyelid Sebaceous Gland Carcinoma: A Report in 10 Cases